Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Options include weekly GLP-1 injections like Wegovy, Zepbound, and Mounjaro
GLP-1 drugs are promising in some areas and need more research in others
Pay close attention to these offerings: Sauces and condiments: Many contain added sugars, additives, or refined seed oils, which may have inflammatory properties
Expert Consensus: American College of Physicians: GLP-1 receptor agonists should be considered for patients with obesity who have not achieved weight loss goals with lifestyle modifications. Endocrine Society: Semaglutide and tirzepatide represent significant advances in obesity pharmacotherapy and should be considered first-line options. Obesity Medicine Association: The dramatic efficacy of GLP-1 and dual agonist medications has fundamentally changed the treatment landscape for obesity. Real-World Effectiveness: Studies of patients using these medications outside clinical trials show: GLP-1s: Similar to clinical trial results (confirming real-world effectiveness) Older medications: Often less effective in real-world than trials (adherence issues) Patient satisfaction: Highest with GLP-1s Bottom Line: Which Works Best
Compounded semaglutide may also be prescribed when medically appropriate
